fibrogen.com (FGEN): Net earnings per share growth forecast for next year
FibroGen, Inc. (FGEN) delegates production and testing to external contractors to focus on the study of fibrosis. The company is currently stagnating due to research failures, necessitating a pipeline refresh. Research centers are based in California, while synthesis is outsourced to CDMO plants. The promising trajectory of EPS growth estimates reflects inflated market expectations, where the -158.80 mark serves as a key metric.
Comprehensive metric breakdowns and analytics for fibrogen.com (FGEN)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- company book value details:
- company total debt and liquidity indicators:
- earnings and valuation multiples information:
FGEN - Company Net Income|Expected Profit FibroGen, Inc.|FGEN - Price to Earnings Multiple|Projected Price to Earnings FibroGen, Inc.|FGEN - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple FibroGen|FGEN - Operating income before deduction of amortization|Earnings per share for the last twelve months FibroGen|FGEN - Earnings per share for the last 12 months|Quarterly EPS earnings growth fibrogen.com|FGEN - Net earnings per share growth this year|Expected earnings per share growth for next year FibroGen, Inc.
Fundamental company valuation:FGEN, FibroGen Corp
Professional managers utilize consensus forecasts to identify early capital rotations between sectors. This metric measures the daily dynamics of expected earnings per share, reflecting the revision of Wall Street analysts' valuations prior to the publication of financial reports. For the defensive biopharmaceutical business of FibroGen, Inc. (FGEN), success depends on drug commercialization, making the consensus growth chart for next year's EPS a key indicator of market confidence in its patent portfolio.
Competitors of FibroGen, Inc.
HLN (Haleon Group) - Earnings growth forecast for next year|Expected net earnings per share growth next year Kenvue Health KVUE|Net earnings per share growth forecast for next year Verona Pharma plc (VRNA)|MENS (jyongbio.com) - Expected earnings per share trend next year|Earnings growth forecast for next year LGND (Ligand)|AMRX (Amneal Pharmaceuticals, Inc.) - Net earnings per share change forecast for next year|Perrigo Company - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Alvotech Biopharmaceuticals ALVO|LQDA: Earnings growth forecast for next year|GLPG (glpg.com) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year ANI Pharmaceuticals, Inc.|MNKD: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Amphastar (AMPH)|PCRX - Expected net earnings per share growth next year|Earnings growth forecast for next year SPRY (ARS Pharmaceuticals)|Net earnings per one share growth forecast for next year theravance.com|Aquestive Therapeutics, Inc. - Earnings growth forecast for next year|Expected net earnings per share growth next year scPharmaceuticals Inc.|tectonictx.com (TECX) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year TNXP|Expected earnings per share growth for next year SXTC|EPRX: Expected earnings per share trend next year|Earnings growth forecast for next year BHST|Consensus forecast of earnings per share growth for next year Invizyne Technologies|Net earnings per share growth forecast for next year Oramed Pharmaceuticals Inc. ORMP|ENTX: Projected earnings per share growth rate for next year|MindWalk Holdings - Earnings growth forecast for next year|abvcpharma.com (ABVC) - Expected earnings per share growth for next year|CPIX (Cumberland Pharmaceuticals Inc.) - Expected earnings per share growth for next year|QNTM - Consensus forecast of earnings per share growth for next year|TELO (Telomir Pharma) - Earnings growth forecast for next year|Rani Therapeutics Inc - Net earnings per share change forecast for next year|Earnings growth forecast for next year SNYR|rallybio.com (RLYB) - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year LEXX (Lexaria Bioscience Corp.)|Pulmatrix Inc (PULM) - Expected net earnings per share growth next year|PTHL - Net earnings per share growth forecast for next year|APM (Aptorum Group Limited) - Projected earnings per share growth rate for next year|Lyra Therapeutics, Inc. (LYRA) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year IBO (Impact BioMedical, Inc.)|TNFA (TNF Pharmaceuticals Inc.) - Earnings growth forecast for next year|YCBD: Expected earnings per share trend next year|Earnings growth forecast for next year PRFX|Earnings growth forecast for next year altamiratherapeutics.com (CYTO)|Net earnings per share growth forecast for next year Lipella Pharmaceuticals LIPO|Expected earnings per share trend next year OPTN|PIRS - Net earnings per share growth forecast for next year|Procaps Group (PROC) - Expected earnings per share growth for next year|PTPI: Earnings growth forecast for next year|Qilian International Corp (QLI) - Earnings growth forecast for next year|Expected earnings per share growth for next year SLRN|TFFP: Expected earnings per share trend next year
